Yao Hong Wei

Summary

Publications

  1. ncbi FR167653 attenuates murine immunological liver injury
    Hong Wei Yao
    Zhejiang Respiratory Drugs Research Laboratory of State Food and Drug Administration of China, School of Medicine, Zhejiang University, Hangzhou 310031, Zhejiang Province, China
    World J Gastroenterol 10:2267-71. 2004
  2. ncbi Effects and mechanisms of FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor, on adjuvant arthritis in rats
    Yao Hong Wei
    Zhejiang Respiratory Drugs Research Laboratory of State Food and Drugs Administration of China, School of Medicine, Zhejiang University, Hangzhou 310031, China
    Int Immunopharmacol 4:1625-32. 2004
  3. ncbi TGF-beta1 induces alveolar epithelial to mesenchymal transition in vitro
    Hong Wei Yao
    Zhejiang Respiratory Drugs Research Laboratory of State Food Drugs Administration of China, School of Medicine, Zhejiang University, Hangzhou 310031, China
    Life Sci 76:29-37. 2004
  4. ncbi Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats
    Yao Hong Wei
    Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou 310031, China
    Dig Dis Sci 49:1589-94. 2004
  5. ncbi Effect and mechanisms of FR167653, a dual inhibitor of TNF-alpha and IL-1, on BCG plus LPS induced-liver injury
    H W Yao
    Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, 310031, China
    Inflamm Res 54:471-7. 2005
  6. ncbi Losartan attenuates bleomycin-induced pulmonary fibrosis in rats
    Hong Wei Yao
    Zhejiang Respiratory Drug Research Laboratory, Food and Drug Administration of China, Zhejiang University School of Medicine, Hangzhou, China
    Respiration 73:236-42. 2006
  7. ncbi Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury
    Hong Wei Yao
    Zhejiang Respiratory Drugs Research Laboratory of State Food and Drugs Administration of China, Hangshou, People s Republic of China
    Clin Exp Pharmacol Physiol 33:793-7. 2006

Collaborators

  • Jun Li
  • Yuan Lu
  • Qing Min Xie
  • Hong Wei Yao
  • Hong-Wei Yao
  • Jian Ping Zhu
  • H W Yao
  • Ji-qiang Chen
  • Ji Qiang Chen
  • Meng Hui Zhao
  • Lian-Gen Mao
  • Lian Gen Mao
  • Jian-ping Zhu
  • L Yue
  • Hui-Fang Tang
  • Yang mei Deng
  • Yang-Mei Deng
  • Hui Fang Tang

Detail Information

Publications7

  1. ncbi FR167653 attenuates murine immunological liver injury
    Hong Wei Yao
    Zhejiang Respiratory Drugs Research Laboratory of State Food and Drug Administration of China, School of Medicine, Zhejiang University, Hangzhou 310031, Zhejiang Province, China
    World J Gastroenterol 10:2267-71. 2004
    ..To study the effect of FR167653 on immunological liver injury (ILI) in mice...
  2. ncbi Effects and mechanisms of FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor, on adjuvant arthritis in rats
    Yao Hong Wei
    Zhejiang Respiratory Drugs Research Laboratory of State Food and Drugs Administration of China, School of Medicine, Zhejiang University, Hangzhou 310031, China
    Int Immunopharmacol 4:1625-32. 2004
    ..The results indicated that FR167653 had a beneficial effect on rats AA due to modulating inflammatory cytokines production of synoviocytes, which played a crucial role in pathogenesis of this disease...
  3. ncbi TGF-beta1 induces alveolar epithelial to mesenchymal transition in vitro
    Hong Wei Yao
    Zhejiang Respiratory Drugs Research Laboratory of State Food Drugs Administration of China, School of Medicine, Zhejiang University, Hangzhou 310031, China
    Life Sci 76:29-37. 2004
    ..These results demonstrated that AECs, under stimulation of TGF-beta1, underwent a conversion process into myofibroblasts in vitro...
  4. ncbi Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats
    Yao Hong Wei
    Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou 310031, China
    Dig Dis Sci 49:1589-94. 2004
    ....
  5. ncbi Effect and mechanisms of FR167653, a dual inhibitor of TNF-alpha and IL-1, on BCG plus LPS induced-liver injury
    H W Yao
    Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, 310031, China
    Inflamm Res 54:471-7. 2005
    ..To investigate the effect of FR167653, a dual inhibitor of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1), on Bacillus Calmétte-Guérin (BCG) plus lipopolysaccharide (LPS) induced-liver injury and its mechanisms...
  6. ncbi Losartan attenuates bleomycin-induced pulmonary fibrosis in rats
    Hong Wei Yao
    Zhejiang Respiratory Drug Research Laboratory, Food and Drug Administration of China, Zhejiang University School of Medicine, Hangzhou, China
    Respiration 73:236-42. 2006
    ..In addition to regulating blood pressure and body fluid homeostasis, the renin-angiotensin system is also involved in lung fibrogenesis...
  7. ncbi Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury
    Hong Wei Yao
    Zhejiang Respiratory Drugs Research Laboratory of State Food and Drugs Administration of China, Hangshou, People s Republic of China
    Clin Exp Pharmacol Physiol 33:793-7. 2006
    ..The inhibitory effect of pravastatin was associated with its effect in decreasing TNF-alpha...